As NEDD4-1 has been previously shown to be associated with cell proliferation, and as its inhibition in our study affected the viability of GBM cells, we evaluated the staining intensity of the proliferation marker Ki-67 through immunofluorescence. This evidence concerns the gene NEDD4 and glioblastoma.